Carnes A.E., Williams J.A. Plasmid fermentation process for DNA immunization applications. Methods Mol Biol 2014, 1143:197-217.
Tudor D., Dubuquoy C., Gaboriau V., Lefevre F., Charley B., Riffault S. TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines. Vaccine 2005, 23(January (10)):1258-1264.
2014. http://www.clinicaltrials.gov/.
Bettan M., Emmanuel F., Darteil R., Caillaud J.M., Soubrier F., Delaere P., et al. High-level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle. Mol Ther 2000, 2(September (3)):204-210.
Mir L.M., Bureau M.F., Gehl J., Rangara R., Rouy D., Caillaud J.M., et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci U S A 1999, 96(April (8)):4262-4267.
Vandermeulen G., Staes E., Vanderhaeghen M.L., Bureau M.F., Scherman D., Preat V. Optimisation of intradermal DNA electrotransfer for immunisation. J Control Release 2007, 124(December (1-2)):81-87.
Gothelf A., Hojman P., Gehl J. Therapeutic levels of erythropoietin (EPO) achieved after gene electrotransfer to skin in mice. Gene Ther 2010, 17(September (9)):1077-1084.
Steinstraesser L., Lam M.C., Jacobsen F., Porporato P.E., Chereddy K.K., Becerikli M., et al. Skin electroporation of a plasmid encoding hCAP-18/LL-37 host defense peptide promotes wound healing. Mol Ther 2014, 22(April (4)):734-742.
Lucas M.L., Heller L., Coppola D., Heller R. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma. Mol Ther 2002, 5(June (6)):668-675.
Daugimont L., Vandermeulen G., Defresne F., Bouzin C., Mir L.M., Bouquet C., et al. Antitumoral and antimetastatic effect of antiangiogenic plasmids in B16 melanoma: higher efficiency of the recombinant disintegrin domain of ADAM 15. Eur J Pharm Biopharm 2011, 78(August (3)):314-319.
Cui Z., Dierling A., Foldvari M. Non-invasive immunization on the skin using DNA vaccine. Curr Drug Deliv 2006, 3(January (1)):29-35.
Daugimont L., Baron N., Vandermeulen G., Pavselj N., Miklavcic D., Jullien M.C., et al. Hollow microneedle arrays for intradermal drug delivery and DNA electroporation. J Membr Biol 2010, 236(July (1)):117-125.
Forg P., von H.P., Dalemans W., Schirrmacher V. Superiority of the ear pinna over muscle tissue as site for DNA vaccination. Gene Ther 1998, 5(June (6)):789-797.
Gothelf A., Gehl J. What you always needed to know about electroporation based DNA vaccines. Hum Vaccin Immunother 2012, 8(November (11)):1694-1702.
Petkov S.P., Heuts F., Krotova O.A., Kilpelainen A., Engstrom G., Starodubova E.S., et al. Evaluation of immunogen delivery by DNA immunization using non-invasive bioluminescence imaging. Hum Vaccin Immunother 2013, 9(October (10)):2228-2236.
Ni J., Nolte B., Vandermeulen G., Preat V., Scherman D., Schirrmacher V., et al. Ear pinna: a privileged DNA electroporation site for inducing strong Th1 immune responses. Open Cancer Immunol J 2009, 2(September):18-30.
Vandermeulen G., Uyttenhove C., De P.E., Van den Eynde B.J., Preat V. Intramuscular electroporation of a P1A-encoding plasmid vaccine delays P815 mastocytoma growth. Bioelectrochemistry 2014, 100(December):112-118.
Vandermeulen G., Athanasopoulos T., Trundley A., Foster K., Preat V., Yanez-Munoz R.J., et al. Highly potent delivery method of gp160 envelope vaccine combining lentivirus-like particles and DNA electrotransfer. J Control Release 2012, 159(May (3)):376-383.
Gajewski T.F., Renauld J.C., Van Pel A., Boon T. Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro. J Immunol 1995, 154(June (11)):5637-5648.
Naslund T.I., Uyttenhove C., Nordstrom E.K., Colau D., Warnier G., Jondal M., et al. Comparative prime-boost vaccinations using Semliki Forest virus, adenovirus, and ALVAC vectors demonstrate differences in the generation of a protective central memory CTL response against the P815 tumor. J Immunol 2007, 178(June (11)):6761-6769.
Uyttenhove C., Godfraind C., Lethe B., Amar-Costesec A., Renauld J.C., Gajewski T.F., et al. The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen. Int J Cancer 1997, 70(January (3)):349-356.
